Authorities in the United States have received approximately 800 reports of heart inflammation that may be connected with vaccines that use the messenger RNA technology — the Pfizer and Moderna vaccines. The majority of cases reported were in patients under 30-years-old.
The instances of myocarditis or pericarditis were reported to the Vaccine Adverse Effects Reporting System (VAERS), a system run jointly by the Center for Disease Control (CDC) and the U.S. Food and Drug Administration (FDA). These numbers document cases through May 31 of this year.
According to the CDC: “Myocarditis is an inflammation of the heart muscle, and pericarditis is inflammation of the outer lining of the heart. In both cases, the body’s immune system causes inflammation in response to an infection or some other trigger.”
The instances of heart inflammation in the United States are consistent with an Israeli study released in early June. That study found that “there is a probable link between receiving the second dose of the (Pfizer) vaccine and the appearance of myocarditis among men aged 16-30.” The Israeli report suggested that the link was more prominent in men aged 16-19 than in other groups.
The instances of heart inflammation have been described as “mild,” although patients generally had to spend an average of four days in the hospital to be treated for symptoms. Out of 285 case reports for which the full disposition is known, 270 patients had been discharged, while 15 remained hospitalized.
Thus far, no deaths have been reported.
The vast majority of the inflammation cases were in males with patients complaining of chest pains and having elevated cardiac enzymes.
Normally, in populations of 16-17 year olds the same as those fully vaccinated with the mRNA vaccines, incidents of myocarditis/pericarditis would be between 2 and 19. The number according to the VAERS report is 79. Similarly, normal numbers for persons 18 – 24 would be 83 cases while the VAERS report shows 196 cases in that age group.
In a Thursday FDA meeting discussing whether COVID-19 vaccines could be used in children as young as six months old, CDC doctors discussed the spike in heart inflammation cases, which are seemingly connected to the mRNA vaccines.
“In the 16- to 17-year-olds and the 18- to 24-year-olds, the observed reports are exceeding the expected based on the known background rates that are published in literature,” said Dr. Tom Shimabukuro, a deputy director at the CDC. Shimabukuro cautioned that not all of the reports would “turn out to be true myocarditis/pericarditis reports.”
There seems to be no doubt that young persons are those at primary risk for this particular side-effect of the mRNA vaccines.
“Of note, of these 528 after second dose with symptom onset within 30 days, over half of them were in these younger age groups, 12 – 24 years old, whereas roughly 9 percent of total doses administered were in those age groups,” Shimabukuru said. “So, we clearly have an imbalance there.”
At the same meeting, Dr. Cody Meissner, a professor of pediatrics at Tufts University School of Medicine, said he was “worried” about the heart issue with young patients, and wondered if there would be scarring of the muscular tissue or long-term arrhythmia as a result of the condition.
“I think that’s unlikely but we don’t know that,” Meissner said. “So, before we start vaccinating millions of adolescents and children, it’s so important to find out what the consequences are.”
As a result of the incidents of heart inflammation that may be connected to the mRNA vaccines, the CDC has announced it will hold an emergency meeting on June 18 to discuss the issue. As of this writing, they have not acted to stop the vaccines from being distributed.
On average, clinical trials for vaccines take 6 or 7 years before vaccines can be judged ready for use. We seem to be finding out now why that’s the case. Because of governmental panic over the COVID-19 pandemic, experimental vaccines have been foisted on the world in less than a year. Is it any wonder we’re seeing the problems we’re seeing?
Whether it’s heart inflammation because of the mRNA vaccines or potentially deadly blood clots due to the AstraZeneca offering, the new vaccines have not yet proven safe or even completely effective. In the days of COVID-19, we are the guinea pigs, the lab rats, and the test subjects.
